health
Dyskinesia
Adverse effectDyskinesia is an adverse health outcome involving abnormal, unwanted movement. It is not a beneficial effect.
See Dyskinesia presented in a clear health context, with the key information organized for quick reading.
These are research findings, not promises. Most options have little evidence, and results differ from person to person.
What can cause it
How likely each one is to cause it, most likely first.
AcupuncturepracticeUnclear
Based on one study. Strongest study: a pooled analysis of several trials.
A pooled analysis of randomized trials in 2025 reported movement disorders, including dyskinesia, in studies involving people with Parkinson's Disease.
Open the Acupuncture page
The expert view shows every study, dose protocol and source.
What can cause it
Interventions reported to bring this on1 listedHighest probability
- →PracticesAcupunctureCertaintyLowSourceClinical1 other source
A pooled analysis of randomized trials in 2025 reported movement disorders, including dyskinesia, in studies involving people with Parkinson's Disease.
Who was studied
- People with a condition
- Parkinsons Disease
Open AcupunctureStudy result
Movement disorders (dyskinesia)
How to read the evidence
Evidence tier — overall strength of the evidence for the whole compound
- StrongWell established — backed by strong, consistent human research.
- ModerateSome genuine support, but mostly from small or lower-quality studies. Promising, not proven.
- PreliminaryEarly-stage evidence — a promising hypothesis, not an established effect yet.
- LimitedVery limited evidence — treat this as a hypothesis, not proof.
- InsufficientNot enough good evidence to draw conclusions yet.
Certainty — how sure we can be that the effect is real
- Very highVery sure — strong, consistent evidence
- HighFairly sure — consistent evidence from good studies
- MediumModerately sure — new studies could change this
- LowNot sure — little or mixed evidence
- Very lowVery unsure — almost no usable evidence
Source — where the data comes from
- Meta-analysisPooled analysis of many trials — the strongest evidence
- RCTRandomized controlled trial — a strong human study design
- ClinicalA human clinical study
- Reference knowledgeFrom general health-science or pharmacology references, not a study of this exact claim
- Animal researchStudied in animals, not humans
- Community reportsAggregated user reports — anecdotal signal, not evidence
- TheoreticalMechanism-based reasoning, not yet tested
Study grade — quality of each underlying study (A best, D weakest)
- AHigh-quality — strong, consistent human trials
- BGood — solid evidence with some limitations
- CModerate — limited, small, or mixed-quality studies
- DWeak — preliminary, indirect, or animal-only
Confidence — how strongly the sources back a finding
A 0–100 score from study quality and agreement
Most supplement evidence is graded C–D. Read it as preliminary signal, not proof.
Full write-up
What is it
Dyskinesia is an adverse health outcome involving abnormal, unwanted movement. It is not a beneficial effect. In this context, observations involving Taurine and Rhodiola Rosea describe possible associations with this outcome, rather than establishing that either intervention consistently causes dyskinesia.
How interventions help
The findings for dyskinesia describe possible symptom aggravation rather than improvement. They come from two different contexts and should not be treated as interchangeable: Rhodiola Rosea was examined alongside cocaine in an animal study, while the taurine-related reports involved taurine-rich food or drink in people.
The Rhodiola Rosea finding suggests that, in the animal model, activity increased during the later observation period and that the stimulant effect of cocaine lasted longer. This does not establish that Rhodiola Rosea causes dyskinesia in people, particularly outside the cocaine-related setting.
The taurine reports describe an acute pattern. In the affected patients, symptoms began about 30 minutes after intake and usually lasted about 3 hours, indicating that any aggravation was temporary in those reports rather than a demonstrated persistent change. The association was linked to taurine-rich food or drink, so it does not establish that every form or amount of taurine has the same effect.
Together, these findings suggest that timing and context matter: one signal was observed after an acute combination involving cocaine in animals, while the other followed acute dietary exposure in people. They do not show that either intervention reliably produces dyskinesia across different populations or circumstances.
Choosing guidance
The two options are not supported in the same way. Taurine has been observed in people, but the evidence comes from a case series rather than a controlled comparison. This can identify a possible short-term symptom pattern, but it cannot establish how often it occurs or show that taurine itself was responsible in every case.
Rhodiola Rosea is supported here only by a study in animals, so its finding does not establish that the same effect occurs in humans. Both options are represented by acute observations rather than evidence about longer-term use. For a choice focused on human relevance, Taurine is the more directly applicable option, while Rhodiola Rosea should be interpreted cautiously because its evidence does not come from human participants.